Trefoil factor-1 (TFF1) enhances oncogenicity of mammary carcinoma cells

Naeem Amiry; Xiangjun Kong; Nethaji Muniraj; Nagarajan Kannan; Prudence M. Grandison; Juan Lin; Yulu Yang; Cécile M. Vouyovitch; Sahra Borges; Jo K. Perry; Hichem C. Mertani; Tao Zhu; Dongxu Liu; Peter E. Lobie

doi:10.1210/en.2009-0066

Trefoil factor-1 (TFF1) enhances oncogenicity of mammary carcinoma cells

Naeem Amiry, Xiangjun Kong, Nethaji Muniraj, Nagarajan Kannan, Prudence M. Grandison, Juan Lin, Yulu Yang, Cécile M. Vouyovitch, Sahra Borges, Jo K. Perry, Hichem C. Mertani, Tao Zhu, Dongxu Liu, Peter E. Lobie

Laboratory Medicine and Pathology

Research output: Contribution to journal › Article › peer-review

47 Scopus citations

Abstract

The functional role of autocrine trefoil factor-1 (TFF1) in mammary carcinoma has not been previously elucidated. Herein, we demonstrate that forced expression of TFF1 in mammary carcinoma cells resulted in increased total cell number as a consequence of increased cell proliferation and survival. Forced expression of TFF1 enhanced anchorage-independent growth and promoted scattered cell morphology with increased cell migration and invasion. Moreover, forced expression of TFF1 increased tumor size in xenograft models. Conversely, RNA interference-mediated depletion of TFF1 in mammary carcinoma cells significantly reduced anchorage-independent growth and migration. Furthermore, neutralization of secreted TFF1 protein by polyclonal antibody decreased mammary carcinoma cell viability in vitro and resulted in regression of mammary carcinoma xenografts. We have therefore demonstrated that TFF1 possesses oncogenic functions in mammary carcinoma cells. Functional antagonism of TFF1 can therefore be considered as a novel therapeutic strategy for mammary carcinoma.

Original language	English (US)
Pages (from-to)	4473-4483
Number of pages	11
Journal	Endocrinology
Volume	150
Issue number	10
DOIs	https://doi.org/10.1210/en.2009-0066
State	Published - Oct 2009

ASJC Scopus subject areas

Endocrinology

Access to Document

10.1210/en.2009-0066

Cite this

@article{a5aa349d557941f5aa007a16e35be54e,

title = "Trefoil factor-1 (TFF1) enhances oncogenicity of mammary carcinoma cells",

abstract = "The functional role of autocrine trefoil factor-1 (TFF1) in mammary carcinoma has not been previously elucidated. Herein, we demonstrate that forced expression of TFF1 in mammary carcinoma cells resulted in increased total cell number as a consequence of increased cell proliferation and survival. Forced expression of TFF1 enhanced anchorage-independent growth and promoted scattered cell morphology with increased cell migration and invasion. Moreover, forced expression of TFF1 increased tumor size in xenograft models. Conversely, RNA interference-mediated depletion of TFF1 in mammary carcinoma cells significantly reduced anchorage-independent growth and migration. Furthermore, neutralization of secreted TFF1 protein by polyclonal antibody decreased mammary carcinoma cell viability in vitro and resulted in regression of mammary carcinoma xenografts. We have therefore demonstrated that TFF1 possesses oncogenic functions in mammary carcinoma cells. Functional antagonism of TFF1 can therefore be considered as a novel therapeutic strategy for mammary carcinoma.",

author = "Naeem Amiry and Xiangjun Kong and Nethaji Muniraj and Nagarajan Kannan and Grandison, {Prudence M.} and Juan Lin and Yulu Yang and Vouyovitch, {C{\'e}cile M.} and Sahra Borges and Perry, {Jo K.} and Mertani, {Hichem C.} and Tao Zhu and Dongxu Liu and Lobie, {Peter E.}",

year = "2009",

month = oct,

doi = "10.1210/en.2009-0066",

language = "English (US)",

volume = "150",

pages = "4473--4483",

journal = "Endocrinology",

issn = "0013-7227",

publisher = "The Endocrine Society",

number = "10",

}

TY - JOUR

T1 - Trefoil factor-1 (TFF1) enhances oncogenicity of mammary carcinoma cells

AU - Amiry, Naeem

AU - Kong, Xiangjun

AU - Muniraj, Nethaji

AU - Kannan, Nagarajan

AU - Grandison, Prudence M.

AU - Lin, Juan

AU - Yang, Yulu

AU - Vouyovitch, Cécile M.

AU - Borges, Sahra

AU - Perry, Jo K.

AU - Mertani, Hichem C.

AU - Zhu, Tao

AU - Liu, Dongxu

AU - Lobie, Peter E.

PY - 2009/10

Y1 - 2009/10

N2 - The functional role of autocrine trefoil factor-1 (TFF1) in mammary carcinoma has not been previously elucidated. Herein, we demonstrate that forced expression of TFF1 in mammary carcinoma cells resulted in increased total cell number as a consequence of increased cell proliferation and survival. Forced expression of TFF1 enhanced anchorage-independent growth and promoted scattered cell morphology with increased cell migration and invasion. Moreover, forced expression of TFF1 increased tumor size in xenograft models. Conversely, RNA interference-mediated depletion of TFF1 in mammary carcinoma cells significantly reduced anchorage-independent growth and migration. Furthermore, neutralization of secreted TFF1 protein by polyclonal antibody decreased mammary carcinoma cell viability in vitro and resulted in regression of mammary carcinoma xenografts. We have therefore demonstrated that TFF1 possesses oncogenic functions in mammary carcinoma cells. Functional antagonism of TFF1 can therefore be considered as a novel therapeutic strategy for mammary carcinoma.

AB - The functional role of autocrine trefoil factor-1 (TFF1) in mammary carcinoma has not been previously elucidated. Herein, we demonstrate that forced expression of TFF1 in mammary carcinoma cells resulted in increased total cell number as a consequence of increased cell proliferation and survival. Forced expression of TFF1 enhanced anchorage-independent growth and promoted scattered cell morphology with increased cell migration and invasion. Moreover, forced expression of TFF1 increased tumor size in xenograft models. Conversely, RNA interference-mediated depletion of TFF1 in mammary carcinoma cells significantly reduced anchorage-independent growth and migration. Furthermore, neutralization of secreted TFF1 protein by polyclonal antibody decreased mammary carcinoma cell viability in vitro and resulted in regression of mammary carcinoma xenografts. We have therefore demonstrated that TFF1 possesses oncogenic functions in mammary carcinoma cells. Functional antagonism of TFF1 can therefore be considered as a novel therapeutic strategy for mammary carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=70349333349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349333349&partnerID=8YFLogxK

U2 - 10.1210/en.2009-0066

DO - 10.1210/en.2009-0066

M3 - Article

C2 - 19589871

AN - SCOPUS:70349333349

SN - 0013-7227

VL - 150

SP - 4473

EP - 4483

JO - Endocrinology

JF - Endocrinology

IS - 10

ER -

Trefoil factor-1 (TFF1) enhances oncogenicity of mammary carcinoma cells

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this